ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,867.08
0.00%
Dow Jones
42,342.24
0.00%
US Dollar vs MXN
20.16232
-0.91%
Brent Oil
72.105
-0.39%
Bitcoin
94,968.27
-2.56%
Pepperstone
Advertisement
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Canadá
  5. TSXV

  6. Zomedica Pharmaceuticals Corp (ZOM) Cotización

Zomedica Pharmaceuticals Corp

Zomedica Pharmaceuticals Corp (ZOM)

Zomedica Corp
ZoomInfo Technologies Inc
0.285
0.00
(0.00%)
Cerrado 20 Diciembre 3:00PM
Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
0.285
Postura de Compra
0.11
Postura de Venta
0.45
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.285 Rango de 52 semanas 0.285
Capitalización de Mercado [m]
279.285M
Precio Anterior
0.285
Precio de Apertura
-
Hora
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
-
Acciones en circulación
979,949,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-7.95
Beneficio por acción (BPA)
-0.04
turnover
25.19M
Beneficio neto
-34.53M

Acerca de Zomedica Pharmaceuticals Corp

Sector
Testing Laboratories
Industria
Unit Inv Tr, Closed-end Mgmt
Sitio web
www.zomedica.com
Sede
Ann Arbor, Michigan, USA
Fundado
2016
Zomedica Pharmaceuticals Corp is listed in the Testing Laboratories sector of the TSX Venture Exchange with ticker ZOM. The last closing price for Zomedica Pharmaceuticals was $0.29. Over the last year, Zomedica Pharmaceuticals shares have traded in a share price range of $ 0.285 to $ 0.285.

Zomedica Pharmaceuticals currently has 979,949,000 shares in issue. The market capitalisation of Zomedica Pharmaceuticals is $279.29 million. Zomedica Pharmaceuticals has a price to earnings ratio (PE ratio) of -7.95.

ZOM Últimas noticias

Más noticias

Sean Whelan Appointed to Board of Directors

ANN ARBOR, Mich., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products...

13 Septiembre 2021
GlobeNewswire Inc.

Zomedica Announces Second Quarter 2021 Financial Results

ANN ARBOR, Mich., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for...

11 Agosto 2021
GlobeNewswire Inc.

Zomedica Announces 2021 Annual Meeting Results

ANN ARBOR, Mich., July 30, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for...

30 Julio 2021
GlobeNewswire Inc.

Zomedica Provides Corporate Update

FOCUSED ON TRUFORMA® INSTRUMENT PLACEMENTS AND BUILDING DIRECT SALES ORGANIZATION ANN ARBOR, Mich., July 06, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the...

06 Julio 2021
GlobeNewswire Inc.

Zomedica Hires Vice President Business Development to Lead Acquisition and Licensing Efforts

Former Elanco Animal Health, Johnson & Johnson, Intuitive Surgical, and Enteromedics Business Development Executive Joins Team to Support Growth Opportunities ANN ARBOR, Mich., May 17, 2021...

17 Mayo 2021
GlobeNewswire Inc.

Zomedica Announces First Quarter 2021 Financial Results

ANN ARBOR, Mich, May 12, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American:ZOM) (“Zomedica” or “Company”), a veterinary health company creating point-of-care diagnostics products for dogs...

12 Mayo 2021
GlobeNewswire Inc.

Zomedica to Build Direct Sales Force for TRUFORMA® Platform

ANN ARBOR, Mich., April 15, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products...

15 Abril 2021
GlobeNewswire Inc.

Zomedica Announces First Commercial Sale of Its Truforma® Platform

ANN ARBOR, Mich., March 16, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products...

16 Marzo 2021
GlobeNewswire Inc.

Zomedica Retires Preferred Shares

ANN ARBOR, Mich., March 08, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products...

08 Marzo 2021
GlobeNewswire Inc.

Zomedica Corp. Announces Year End 2020 Financial Results

ANN ARBOR, Mich., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Zomedica Corp. (NYSE American:ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for...

26 Febrero 2021
GlobeNewswire Inc.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1000.2850.2850.28500CS
4000.2850.2850.28500CS
12000.2850.2850.28500CS
26000.2850.2850.28500CS
52000.2850.2850.28500CS
156000.2850.2850.28500CS
260-0.155-35.22727272730.440.450.285150.31032578CS

ZOM - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Zomedica Pharmaceuticals?
El precio actual de las acciones de Zomedica Pharmaceuticals es $ 0.285
¿Cuántas acciones de Zomedica Pharmaceuticals están en circulación?
Zomedica Pharmaceuticals tiene 979,949,000 acciones en circulación
¿Cuál es la capitalización de mercado de Zomedica Pharmaceuticals?
La capitalización de mercado de Zomedica Pharmaceuticals es CAD 279.29M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Zomedica Pharmaceuticals?
Zomedica Pharmaceuticals ha negociado en un rango de $ 0.285 a $ 0.285 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Zomedica Pharmaceuticals?
El ratio precio/beneficio de Zomedica Pharmaceuticals es -7.95
¿Cuál es el ratio de efectivo a ventas de Zomedica Pharmaceuticals?
El ratio de efectivo a ventas de Zomedica Pharmaceuticals es 10.89
¿Cuál es la moneda de reporte de Zomedica Pharmaceuticals?
Zomedica Pharmaceuticals presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Zomedica Pharmaceuticals?
El último ingresos anual de Zomedica Pharmaceuticals es USD 25.19M
¿Cuál es el último beneficio anual de Zomedica Pharmaceuticals?
El último beneficio anual de Zomedica Pharmaceuticals es USD -34.53M
¿Cuál es la dirección registrada de Zomedica Pharmaceuticals?
La dirección registrada de Zomedica Pharmaceuticals es 100 PHOENIX DRIVE, SUITE 125, ANN ARBOR, MICHIGAN, 48108
¿Cuál es la dirección del sitio web de Zomedica Pharmaceuticals?
La dirección del sitio web de Zomedica Pharmaceuticals es www.zomedica.com
¿En qué sector industrial opera Zomedica Pharmaceuticals?
Zomedica Pharmaceuticals opera en el sector UNIT INV TR, CLOSED-END MGMT

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
AAAAAuralite Investments Inc
$ 0.265
(0.00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0.04
(0.00%)
0
AAAlba Minerals Ltd
$ 0.03
(0.00%)
0
A.HArmor Minerals Inc
$ 0.30
(0.00%)
0
AArmor Minerals Inc
$ 0.45
(0.00%)
0
AAAAAuralite Investments Inc
$ 0.265
(0.00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0.04
(0.00%)
0
AAAlba Minerals Ltd
$ 0.03
(0.00%)
0
A.HArmor Minerals Inc
$ 0.30
(0.00%)
0
AArmor Minerals Inc
$ 0.45
(0.00%)
0
AAAAAuralite Investments Inc
$ 0.265
(0.00%)
0
AAA.PFirst Tidal Acquisition Corp
$ 0.04
(0.00%)
0
AAAlba Minerals Ltd
$ 0.03
(0.00%)
0
A.HArmor Minerals Inc
$ 0.30
(0.00%)
0
AArmor Minerals Inc
$ 0.45
(0.00%)
0

Discusión

Ver feed completo
ITYS ITYS 3 minutos hace
THIS WAS COMPANY'S UPDATE it last financials :-)
Basically a go screw the open market investors :-)

Note 12 – Subsequent Events Management evaluated all additional events through the date the consolidated financial statements were available to be issued. Based upon this review,
GEVI
dirkv dirkv 3 minutos hace
wowww

TAOP: Pre-Market Share Volume
48,154,804
Pre-Market High $1.05
dirkv dirkv 3 minutos hace
wowww

TAOP: Pre-Market Share Volume
48,154,804
Pre-Market High $1.05
flipper44 flipper44 3 minutos hace
That’s one possible explanation.
NWBO
dewophile dewophile 3 minutos hace
The market clearly thinks the RSV drug is going to fail. The bear case is basically that other drugs with positive challenge data failed when tested in real world scenarios, including Zeli in standard risk adults. The only one that nominally succeeded - ziresovir, Ark bio's fusion inhibitor - had a
JNJ PFE
TKS PARTY TKS PARTY 3 minutos hace
Mattordaddy, literally laughed out loud, multiple secret blending and distribution locations, and sworn to secrecy so not one shareholder actually knows. We wonder why are stock is less than 80 cents. No distribution for California, not one announced Dynamo contract in nearly 4 years and the PR from
CBRF
stocktowatch stocktowatch 4 minutos hace
$ILLR Triller Group shared a bold strategic vision and exciting updates during our Investor Day, highlighting innovation, growth, and transformation across our ecosystem.
https://x.com/triller_IR/status/1870108542126174637
ILLR
stealofadeal stealofadeal 4 minutos hace
$GEVI Some people have no purpose and nothing better to do but stalk a GEVI board. Dude got fired by Steve Conboy and easy to know who it is here. GEVI is solid and holding for the big push.
GEVI
chemist72 chemist72 4 minutos hace
I have 2 primary examples of PRs that were completely misleading and primarily fraudulent.

I don't know how we can prove that those PRs caused us to buy more shares of MVNT, but they certainly encouraged me to do so. I will try to search through MVNT's posts on X over the weekend. I w
MVNT
Curt D Curt D 4 minutos hace
I'm going to begin correcting everyone's English because what I'm seeing is absolutely intolerable

You won't make any friends. English is a second language to some of the posters here. Can you speak multiple languages?
RDAR
al44 al44 5 minutos hace
Congressional dirty dealing is now on full display

By Anony Mee

The proposed language of the next continuing resolution seems to be back on the drawing board. One of the big questions, though, about the 1,547-page monstrosity that just died in the House is how we can ho
quester614 quester614 5 minutos hace
You act like YOU have nothing to do with that. After 4 years of BS AND CHEAP BASELESS INSULTS of others. You are truly clueless.
XERI
Rambo Rell Rambo Rell 5 minutos hace
$ILLR 🚀 Big moves ahead! Triller Group just unveiled an ambitious vision and exciting updates during their Investor Day. With innovation and growth in the spotlight, this could be a game-changer for the creator economy. 🌟

🔗 Read more: https://trillercorp.com/tr
ILLR
Gizzer211 Gizzer211 5 minutos hace
UMAV news
UMAV
Rambo Rell Rambo Rell 5 minutos hace
$ILLR 🚀 Big moves ahead! Triller Group just unveiled an ambitious vision and exciting updates during their Investor Day. With innovation and growth in the spotlight, this could be a game-changer for the creator economy. 🌟

🔗 Read more: https://trillercorp.com/tr
ILLR
WeTheMarket WeTheMarket 5 minutos hace
Repost from Stocktwits board, courtesy of Gio_F.

One of the first places where the final 45V rule will likely appear is here: https://home.treasury.gov/news/press-releases Last indication is still "before year end". To consider: last year's draft 45V rule was released on Friday, Dece
NKLA
learningcurve2020 learningcurve2020 5 minutos hace
Almost brought the entire market down.  LOL
NWBO
flipper44 flipper44 5 minutos hace
It could be an accounting error, but you are unnecessarily distorting what I am saying. I am saying why sell cheap shares if a better source of funding became available? You just attack the person and distort the question.
NWBO
Alley-oop Alley-oop 5 minutos hace
No. I just provided the general process for fins.
GRLT
Smartypants2 Smartypants2 5 minutos hace
I was obviously referring to KZ's use of ALL-CAPS in general, you dimwit! The fact that he didn't capitalize one word in one particular post is irrelevant.
XERI
gawti88 gawti88 6 minutos hace
haha, I got big commission cheque coming next week. Deploying gonna buy 300k+ more.
CEOS
BurgerKing82 BurgerKing82 6 minutos hace
This looks ready to pop
WORX
RIGATONI RIGATONI 6 minutos hace
Refresher > > >



https://northerndynastyminerals.com/pebble-project/project-overview/


The Pebble Project is located in southwest Alaska. Northern Dynasty is 100% owner of the Pebble Partnership, which is advancing the world-class Pebble deposit t
Golden Cross Golden Cross 6 minutos hace
📰 News Out 📰 Triller Group Inc. Unveils Bold Vision and Exciting Business Updates During Investor Day
https://www.benzinga.com/pressreleases/24/12/g42616393/triller-group-inc-unveils-bold-vision-and-exciting-business-updates-during-investor-day

$ILLR
ILLR

Su Consulta Reciente

TSXV
ZOM
Zomedica Pharmaceuticals
NASDAQ
QQLV
Invesco QQQ Low Volatili...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados